Company Announcement no. 6/2014
To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 17 March, 2014
Notice to Convene Annual General Meeting
The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 ("the Company), hereby convenes the annual general meeting in the Company which will be held
Wednesday 9 April 2014 at 1 p.m.
at Søhuset, Venlighedsvej 10, 2970 Hørsholm, Denmark.
Agenda
- Report by the Company's board of directors on the Company’s activities during the past financial year.
- Proposal by the board of directors to prepare and submit the annual and interim financial reports in English only and amendment of the articles of association in accordance therewith.
- Presentation of the audited annual report for approval.
- Resolution on application of profits or covering of losses as per the approved annual report.
- Approval of fee to the board of directors for the financial year 2014.
- Election of members to the board of directors.
- Election of auditor.
- Proposal by the board of directors for approval of remuneration policy including updated general guidelines for incentive-based remuneration to members of the board of directors and executive management and amendment of the articles of association in accordance therewith.
- Proposal by the board of directors on authorization to the Company to acquire own shares.
- Proposal by the board of directors on authorization to the chairman of the annual general meeting.
